seed
Stage
2018
Founded
About
Glycovaxin is a biotechnology company developing a new generation of vaccines against bacterial infections. They utilize synthetic carbohydrate chemistry to create innovative vaccine candidates.
Explore Glycovaxin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.